GlassScriptPhysician profile
Jessica Kaprive
NPI 1053997601
$1,238.63
in general payments reported to CMS, 2019-2025
16 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $376 · 2024: $545 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.65 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $276.79 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $179.98 | 2023-2024 | |
| Janssen Biotech, INC. | $157.88 | 2024-2025 | Tremfya |
| Ucb, INC. | $98.40 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $91.21 | 2024-2025 | |
| Abbvie INC. | $62.85 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.75 | 2024 | Spevigo |
| Amgen INC. | $56.75 | 2024-2025 | Otezla |
| Pfizer INC. | $55.30 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $52.45 | 2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $35.18 | 2023 | Dupixent |
| Ani Pharmaceuticals, INC. | $27.69 | 2025 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $24.22 | 2023 | Winlevi |
| Incyte Corporation | $22.23 | 2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $18.06 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.89 | 2025 | Ebglyss, Taltz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Kaprive listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.